Faculty Opinions recommendation of Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial.

AimsTo compare the population proportion at high risk of cardiovascular disease (CVD) using the Norwegian NORRISK 1 that predicts 10-year risk of CVD mortality and the Norwegian national guidelines from 2009, with the updated NORRISK 2 that predicts 10-year risk of both fatal and non-fatal risk of CVD and the Norwegian national guidelines from 2017.MethodsWe included participants from the Norwegian population-based Tromsø Study (2015–2016) aged 40–69 years without a history of CVD (n=16 566). The total proportion eligible for intervention was identified by NORRISK 1 and the 2009 guidelines (serum total cholesterol ≥8 mmol/L, systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg) and NORRISK 2 and the 2017 guidelines (serum total cholesterol ≥7 mmol/L, low density lipoprotein (LDL) cholesterol ≥5 mmol/L, systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg).ResultsThe total proportion at high risk as defined by a risk score was 12.0% using NORRISK 1 and 9.8% using NORRISK 2. When including single risk factors specified by the guidelines, the total proportion eligible for intervention was 15.5% using NORRISK 1 and the 2009 guidelines and 18.9% using NORRISK 2 and the 2017 guidelines. The lowered threshold for total cholesterol and specified cut-off for LDL cholesterol stand for a large proportion of the increase in population at risk.ConclusionThe population proportion eligible for intervention increased by 3.4 percentage points from 2009 to 2017 using the revised NORRISK 2 score and guidelines.

Download Full-text

In hypertensive patients with elevated risk of cardiovascular disease, targeting systolic blood pressure to less than 120 mm Hg significantly reduces the rate of fatal and non-fatal cardiovascular events as well as death from any cause

Evidence-Based Medicine ◽

10.1136/ebmed-2016-110397 ◽

2016 ◽

Vol 21 (3) ◽

pp. 101-101

Author(s):

Mina Owlia ◽

Sripal Bangalore

Keyword(s):

Blood Pressure ◽

Cardiovascular Disease ◽

Systolic Blood Pressure ◽

Cardiovascular Events ◽

Elevated Risk ◽

Hypertensive Patients

Download Full-text

The effects of foot reflexology on blood pressure and heart rate: A randomized clinical trial in stage‐2 hypertensive patients

Journal of Clinical Hypertension ◽

10.1111/jch.14103 ◽

2020 ◽

Author(s):

Praew Kotruchin ◽

Supap Imoun ◽

Thapanawong Mitsungnern ◽

Patcharin Aountrai ◽

Maneenuch Domthaisong ◽

...

Keyword(s):

Blood Pressure ◽

Clinical Trial ◽

Heart Rate ◽

Randomized Clinical Trial ◽

Hypertensive Patients

Download Full-text

Effectiveness of Acupressure on the Taichong Acupoint in Lowering Blood Pressure in Patients with Hypertension: A Randomized Clinical Trial

Evidence-based Complementary and Alternative Medicine ◽

10.1155/2016/1549658 ◽

2016 ◽

Vol 2016 ◽

pp. 1-9 ◽

Cited By ~ 2

Author(s):

Gan-Hon Lin ◽

Wei-Chun Chang ◽

Kuan-Ju Chen ◽

Chen-Chen Tsai ◽

Sung-Yuan Hu ◽

...

Keyword(s):

Blood Pressure ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Care Plan ◽

Control Group ◽

Optimal Dosage ◽

Hypertensive Patients ◽

Significant Difference ◽

And Control ◽

Experimental Group

Objectives. To evaluate the effectiveness of acupressure on the Taichong acupoint in lowering systolic and diastolic blood pressure (BP) in hypertensive patients.Methods. Eighty patients with hypertension attending a cardiology outpatient department in central Taiwan were included in this randomized clinical trial. Acupressure was applied to the Taichong acupoint in the experimental group (n=40) and to the first metatarsal (sham acupoint) in the control group (n=40). Blood pressure was measured by electronic monitoring before and immediately 15 min and 30 min after acupressure.Results. The average age of the experimental and control participants was 59.3 ± 9.2 years and 62.7 ± 8.4 years, respectively. The two groups were similar for demographics and antihypertensive drug use. Mean systolic and diastolic BP in the experimental group decreased at 0, 15, and 30 min after acupressure (165.0/96.3, 150.4/92.7, 145.7/90.8, and 142.9/88.6 mmHg); no significant changes occurred in the control group. There was a significant difference in systolic and diastolic BP between the experimental and control groups immediately and 15 and 30 min after acupressure (p<0.05).Conclusion. Acupressure on the Taichong acupoint can lower BP in hypertensive patients and may be included in the nursing care plan for hypertension. However, additional studies are needed to determine the optimal dosage, frequency, and long-term effects of this therapy.

Download Full-text